Is WWHC or QYLD a better dividend investment in 2026?

WWHC currently yields 250.00% with a 5% 5-year dividend growth rate. QYLD yields 11.92% with -2.1% growth. The better choice depends on your goal: WWHC offers higher current income.

What is the dividend yield difference between WWHC and QYLD?

WWHC has a forward dividend yield of 250.00% ($2.00/share annually). QYLD yields 11.92% ($2.04/share annually). The yield gap is 238.08 percentage points.

Home › Compare › WWHC vs QYLD

WWHC vs QYLD: Dividend Comparison 2026

WWHC yields 250.00% · QYLD yields 11.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 WWHC wins by $460.87M in total portfolio value

INVESTMENT

TIME HORIZON10 years

WWHC

● Live price

250.00%

Share price

$0.80

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$460.90M

Annual income

$257,938,329.48

Full WWHC calculator →

QYLD

Global X Nasdaq 100 Covered Call ETF

● Live price

11.92%

Share price

$17.15

Annual div

$2.04

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.4K

Annual income

$5,659.31

Full QYLD calculator →

Portfolio growth — WWHC vs QYLD

📍 WWHC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	WWHC	QYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, WWHC + QYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

WWHC pays

QYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WWHC

Annual income on $10K today (after 15% tax)

$21,250.00/yr

After 10yr DRIP, annual income (after tax)

$219,247,580.06/yr

QYLD

Annual income on $10K today (after 15% tax)

$1,013.51/yr

After 10yr DRIP, annual income (after tax)

$4,810.41/yr

At 15% tax rate, WWHC beats the other by $219,242,769.64/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WWHC + QYLD for your $10,000?

WWHC: 50%QYLD: 50%

100% QYLD50/50100% WWHC

Portfolio after 10yr

$230.46M

Annual income

$128,971,994.40/yr

Blended yield

55.96%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WWHC buys

QYLD buys

No recent congressional trades found for WWHC or QYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricWWHCQYLD

Forward yield	250.00% ✓	11.92%
Annual dividend / share	$2.00	$2.04 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$460.90M ✓	$25.4K
Annual income after 10y	$257,938,329.48 ✓	$5,659.31
Total dividends collected	$439.24M ✓	$27.1K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: WWHC vs QYLD ($10,000, DRIP)

Year	WWHC Portfolio	WWHC Income/yr	QYLD Portfolio	QYLD Income/yr	Gap
1← crossover	$35,700	$25,000.00	$10,352	$1,192.36	+$25.3K → WWHC
2	$121,610	$83,411.21	$10,830	$1,347.57	+$110.8K → WWHC
3	$395,671	$265,547.68	$11,460	$1,539.07	+$384.2K → WWHC
4	$1,230,830	$807,462.69	$12,275	$1,777.84	+$1.22M → WWHC
5	$3,664,475	$2,347,486.25	$13,323	$2,078.95	+$3.65M → WWHC
6	$10,452,787	$6,531,799.39	$14,667	$2,463.34	+$10.44M → WWHC
7	$28,597,316	$17,412,833.72	$16,396	$2,960.57	+$28.58M → WWHC
8	$75,121,556	$44,522,427.99	$18,631	$3,612.97	+$75.10M → WWHC
9	$189,683,639	$109,303,574.11	$21,548	$4,482.15	+$189.66M → WWHC
10	$460,899,823	$257,938,329.48	$25,398	$5,659.31	+$460.87M → WWHC

WWHC vs QYLD: Complete Analysis 2026

WWHC — Stock

W World Corp., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat a range of metabolic and nervous system disorders. The company focuses on the disorders of the brain-gut axis, pain/inflammation, and autoimmune, as well as gout disorders. Its lead compounds under clinically development include Levotofisopam, a non-sedating agent for the treatment of Gout; and Dextofisopam, a non-serotonergic agent, which has completed Phase IIa and Phase IIb clinical trials for the treatment of irritable bowel syndrome. The company was founded in 1990 and is headquartered in North Las Vegas, Nevada.

Full WWHC Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

📬

Get this WWHC vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WWHC vs SCHD WWHC vs JEPI WWHC vs O WWHC vs KO WWHC vs MAIN WWHC vs XYLD WWHC vs JEPQ WWHC vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.